Anti-Human HHLA2/B7-H7 VHH (SAA2684) from ProteoGenix; catalogue ARO-A23122; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Are you looking for a powerful tool to enhance your biotech research? Look no further than Anti-Human HHLA2/B7-H7 VHH (SAA2684). This cutting-edge product is specifically designed to meet the needs of biotech researchers, providing unparalleled results and efficiency.
Anti-Human HHLA2/B7-H7 VHH (SAA2684) is a single-domain antibody that specifically targets the human HHLA2/B7-H7 protein. This protein plays a crucial role in regulating immune responses and has been linked to various diseases, making it an important target for biotech research.
This innovative product has a wide range of applications in the biotech field. It can be used for protein detection, purification, and quantification, making it an essential tool for protein analysis and characterization. Additionally, Anti-Human HHLA2/B7-H7 VHH (SAA2684) can be used in drug discovery and development, as well as in diagnostic assays.
Anti-Human HHLA2/B7-H7 VHH (SAA2684) has been extensively tested and validated for its effectiveness in various experimental settings. It has shown promising results in inhibiting HHLA2/B7-H7-mediated immune suppression, making it a potential therapeutic target for cancer and autoimmune diseases. Furthermore, it has been used in a variety of research studies to elucidate the role of HHLA2/B7-H7 in immune regulation and disease progression.
Our Anti-Human HHLA2/B7-H7 VHH (SAA2684) is a versatile and reliable tool for biotech research. With its high specificity and sensitivity, it allows for accurate and efficient detection and analysis of HHLA2/B7-H7. This product is also highly customizable, with various conjugation and labeling options available to meet your specific research needs.
To summarize, Anti-Human HHLA2/B7-H7 VHH (SAA2684) is a powerful and versatile tool for biotech research. Its unique ability to target the human HHLA2/B7-H7 protein makes it an essential component in protein analysis, drug discovery, and diagnostic assays. With its proven effectiveness in a variety of experimental settings, this product is a must-have for any biotech researcher. Try Anti-Human HHLA2/B7-H7 VHH (SAA2684) today and take your research to the next level.
ProteoGenix catalogue number ARO-A23122. For research use only.
Target: HERV-H LTR-associating protein 2, HHLA2, Human endogenous retrovirus-H long terminal repeat-associating protein 2; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
